Results 141 to 150 of about 2,419 (196)

Electro-oxidation of formoterol fumarate on the surface of novel poly(thiazole yellow-G) layered multi-walled carbon nanotube paste electrode. [PDF]

Sci Rep, 2021
Hareesha N, Manjunatha JG.
europepmc   +1 more source

Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studies. [PDF]

Ther Adv Respir Dis
Bednarczyk A, Aurivillius M, Jassal M, Shah M, Raphiou I, Petullo D, Xu J, Heijer M, Sychowicz K, Collison K, Silva C, Reddy J, Han D, Goldwater R, Gillen M, Patel M.   +15 more
europepmc   +1 more source

Glycopyrrolate/formoterol fumarate MDI in mild-to-moderate chronic obstructive pulmonary disease (PIONEER): a protocol for a randomised, double-blind, placebo-controlled trial. [PDF]

BMJ Open Respir Res
Wang FY, Wang ZH, Xu JX, Liang ZY, Ran PX, Zhou YM, Gao Y, Shi WJ, Jiang WY, Li YQ, Zhang DY, Chen RC, Guan WJ, Zhong NS, Zheng JP.   +14 more
europepmc   +1 more source

Green Assessment of Sensitive Spectrofluorimetric Methods for Simultaneous Estimation of Formoterol Fumarate and Fluticasone Propionate Using a Micelle-Mediated Approach. [PDF]

J Fluoresc
Adawy HA, Hegazy MA, Saad SS, Boltia SA.
europepmc   +1 more source

Characteristics of Patients Initiated on Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Single Inhaler Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Population-Based Observational Study. [PDF]

Int J Chron Obstruct Pulmon Dis
Deslee G, Fabry-Vendrand C, Salmi E, Poccardi N, Coriat A, Ghout I, Eteve-Pitsaer C, Adderley NJ, Leleu H.   +8 more
europepmc   +1 more source

Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease. [PDF]

Adv Ther
Mannino D, Weng S, Germain G, Boudreau J, Tardif-Samson A, Forero-Schwanhaeuser S, Laliberté F, Gravelle P, Compton CH, Noorduyn SG, Paczkowski R.   +10 more
europepmc   +1 more source

Comparison of the efficacy of noninvasive positive pressure ventilation combined with and without budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in the treatment of acute exacerbations of Chronic Obstructive Pulmonary Disease. [PDF]

Pak J Med Sci
Sun J, Xu X, Wang F.
europepmc   +1 more source

Safety of budesonide/glycopyrronium/formoterol fumarate dihydrate delivered by HFO-1234ze versus HFA-134a in chronic obstructive pulmonary disease: a phase 3, multi-site, randomised, double-blind, parallel-group, active-comparator study. [PDF]

EClinicalMedicine
Usmani OS, Martinez FJ, Pandya H, Camiolo M, Bednarczyk A, Kucz K, Kokot M, Gottfridsson C, Aurivillius M, Pettersson L, Mei J, Skansen K, Bell JL, Petullo D, Collison K, Bondarov P, Jassal M, Patel M.   +17 more
europepmc   +1 more source

Extrafine formulation of beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurized metered-dose inhaler in the treatment of asthma: a review. [PDF]

Ther Adv Respir Dis
Ridolo E, Milanese M, Barone A, Nicoletta F, Ottoni M, Cosini FF, Passalacqua G, Lombardi C.   +7 more
europepmc   +1 more source

A comparison of the efficacy and safety of combined aclidinium bromide and formoterol fumarate in the treatment of chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis. [PDF]

Medicine (Baltimore), 2020
Lu H, Huang YT, Chen HJ, Chen PF.
europepmc   +1 more source